| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
41,553 |
34,455 |
$1.63M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,499 |
4,583 |
$327K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
8,897 |
7,802 |
$324K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,313 |
3,794 |
$279K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
9,378 |
8,076 |
$248K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,760 |
2,477 |
$177K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
8,266 |
6,915 |
$173K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,893 |
2,468 |
$172K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12,254 |
10,843 |
$119K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,110 |
965 |
$76K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
1,457 |
1,230 |
$73K |
| 90832 |
Psychotherapy, 30 minutes with patient |
2,027 |
1,855 |
$55K |
| 96160 |
|
2,492 |
2,221 |
$36K |
| 96127 |
|
6,489 |
5,706 |
$32K |
| 99177 |
|
4,425 |
3,899 |
$28K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,836 |
3,288 |
$27K |
| 96161 |
|
2,179 |
1,711 |
$26K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,514 |
1,261 |
$22K |
| 92551 |
|
2,805 |
2,451 |
$19K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
614 |
450 |
$10K |
| 94760 |
|
4,253 |
2,952 |
$7K |
| 36416 |
|
3,159 |
2,689 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
73 |
62 |
$4K |
| 99381 |
|
29 |
27 |
$2K |
| 83655 |
|
191 |
166 |
$2K |
| 92015 |
Determination of refractive state |
99 |
67 |
$2K |
| 90651 |
|
277 |
235 |
$2K |
| 81003 |
|
902 |
717 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
36 |
35 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
27 |
26 |
$1K |
| 90461 |
|
3,740 |
3,380 |
$1K |
| 90734 |
|
157 |
128 |
$978.53 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
64 |
56 |
$911.88 |
| 90791 |
Psychiatric diagnostic evaluation |
14 |
14 |
$717.30 |
| 90686 |
|
1,475 |
1,273 |
$679.55 |
| 90670 |
|
1,979 |
1,746 |
$471.58 |
| 90619 |
|
62 |
54 |
$350.49 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
75 |
43 |
$192.60 |
| 94664 |
|
14 |
12 |
$171.19 |
| 90715 |
|
125 |
111 |
$147.09 |
| 99173 |
|
21 |
17 |
$134.58 |
| 90688 |
|
276 |
263 |
$132.01 |
| 90633 |
|
589 |
511 |
$131.01 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
74 |
54 |
$129.65 |
| 90698 |
|
1,030 |
918 |
$127.59 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
157 |
122 |
$122.21 |
| 90696 |
|
101 |
83 |
$67.82 |
| 90672 |
|
128 |
120 |
$23.70 |
| 90658 |
|
66 |
66 |
$21.86 |
| 90680 |
|
949 |
841 |
$0.08 |
| 90744 |
|
294 |
248 |
$0.04 |
| 90716 |
|
112 |
73 |
$0.00 |
| 90697 |
|
230 |
207 |
$0.00 |
| 90723 |
|
65 |
55 |
$0.00 |
| 90710 |
|
76 |
67 |
$0.00 |
| 90707 |
|
126 |
85 |
$0.00 |
| 90671 |
|
265 |
239 |
$0.00 |
| 90648 |
|
31 |
26 |
$0.00 |
| 90685 |
|
47 |
41 |
$0.00 |